191 related articles for article (PubMed ID: 8454901)
1. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ
J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901
[TBL] [Abstract][Full Text] [Related]
2. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
Alkemade JA; Molhuizen HO; Ponec M; Kempenaar JA; Zeeuwen PL; de Jongh GJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC; Schalkwijk J
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2335-42. PubMed ID: 7983189
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.
Nonomura K; Yamanishi K; Yasuno H; Nara K; Hirose S
J Invest Dermatol; 1994 Jul; 103(1):88-91. PubMed ID: 8027586
[TBL] [Abstract][Full Text] [Related]
4. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
Kuijpers AL; Zeeuwen PL; de Jongh GJ; van de Kerkhof PC; Alkemade HA; Schalkwijk J
Arch Dermatol Res; 1996 Oct; 288(11):641-7. PubMed ID: 8931865
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
Alkemade H; van de Kerkhof P; Schalkwijk J
J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
[TBL] [Abstract][Full Text] [Related]
6. Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis.
Kuijpers AL; Alkemade HA; Schalkwijk J; van de Kerkhof PC
Acta Derm Venereol; 1995 Mar; 75(2):110-3. PubMed ID: 7604637
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of SKALP/Elafin in human epidermal tumors.
Alkemade HA; Molhuizen HO; van Vlijmen-Willems IM; van Haelst UJ; Schalkwijk J
Am J Pathol; 1993 Dec; 143(6):1679-87. PubMed ID: 8256855
[TBL] [Abstract][Full Text] [Related]
8. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.
Molhuizen HO; Alkemade HA; Zeeuwen PL; de Jongh GJ; Wieringa B; Schalkwijk J
J Biol Chem; 1993 Jun; 268(16):12028-32. PubMed ID: 7685029
[TBL] [Abstract][Full Text] [Related]
9. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
Alkemade HA; van Vlijmen-Willems IM; van Haelst UJ; van de Kerkhof PC; Schalkwijk J
J Pathol; 1994 Oct; 174(2):121-9. PubMed ID: 7965407
[TBL] [Abstract][Full Text] [Related]
11. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
[TBL] [Abstract][Full Text] [Related]
12. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.
Schalkwijk J; de Roo C; de Jongh GJ
Biochim Biophys Acta; 1991 Feb; 1096(2):148-54. PubMed ID: 2001428
[TBL] [Abstract][Full Text] [Related]
13. Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
Alkemade HA; de Jongh GJ; Arnold WP; van de Kerkhof PC; Schalkwijk J
J Invest Dermatol; 1995 Feb; 104(2):189-93. PubMed ID: 7829874
[TBL] [Abstract][Full Text] [Related]
14. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
Pfundt R; van Ruissen F; van Vlijmen-Willems IM; Alkemade HA; Zeeuwen PL; Jap PH; Dijkman H; Fransen J; Croes H; van Erp PE; Schalkwijk J
J Clin Invest; 1996 Sep; 98(6):1389-99. PubMed ID: 8823304
[TBL] [Abstract][Full Text] [Related]
15. Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis.
Schalkwijk J; Chang A; Janssen P; De Jongh GJ; Mier PD
Br J Dermatol; 1990 May; 122(5):631-41. PubMed ID: 2354116
[TBL] [Abstract][Full Text] [Related]
16. Expression of SKALP/elafin during wound healing in human skin.
van Bergen BH; Andriessen MP; Spruijt KI; van de Kerkhof PC; Schalkwijk J
Arch Dermatol Res; 1996 Jul; 288(8):458-62. PubMed ID: 8844125
[TBL] [Abstract][Full Text] [Related]
17. Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis.
Kuijpers AL; Schalkwijk J; Rulo HF; Peperkamp JJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 1997 Jul; 137(1):123-9. PubMed ID: 9274639
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of lipocortins in normal and psoriatic human skin.
Ikai K; Shimizu K; Ando Y; Furukawa F; Imamura S; Kannagi R
Arch Dermatol Res; 1993; 285(5):296-9. PubMed ID: 8379691
[TBL] [Abstract][Full Text] [Related]
19. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.
Molhuizen HO; Zeeuwen PL; Olde Weghuis D; Geurts van Kessel A; Schalkwijk J
Cytogenet Cell Genet; 1994; 66(2):129-31. PubMed ID: 8287685
[TBL] [Abstract][Full Text] [Related]
20. Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion.
Van de Kerkhof PC; Kuppens LH; Van Vlijmen Y; Schalkwijk J
Br J Dermatol; 1991 Jan; 124(1):10-2. PubMed ID: 1847066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
